Emergo Therapeutics Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Out of Business

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Out of Business

Emergo Therapeutics General Information

Description

Developer of therapeutic drugs designed to improve immune system function in various indications. The company's drugs target the release of inflammatory molecules including developing drugs for the treatment of uncomplicated influenza and improving the immune system, enabling doctors to prevent damaging symptoms and outcomes of seemingly unrelated diseases.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 6208 Fayetteville Road
  • Suite 104
  • Durham, NC 27713
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 6208 Fayetteville Road
  • Suite 104
  • Durham, NC 27713
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Emergo Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Out of Business 30-Sep-2026 Completed Out of Business
5. Later Stage VC 06-May-2022 Completed Generating Revenue
4. Early Stage VC (Series B) 12-Oct-2020 Completed Clinical Trials - Phase 2
3. Debt - General 16-Oct-2019 Completed Clinical Trials - Phase 1
2. Early Stage VC (Series A) 23-May-2018 $12M $12.1M Completed Clinical Trials - Phase 1
1. Debt - General 23-Aug-2017 $75K $75K Completed Clinical Trials - Phase 1
To view Emergo Therapeutics’s complete valuation and funding history, request access »

Emergo Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view Emergo Therapeutics’s complete cap table history, request access »

Emergo Therapeutics Patents

Emergo Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3040420-A1 Mast cell stabilizers for treatment of chronic inflammatory conditions Active 18-Oct-2016
EP-3528809-A1 Mast cell stabilizers for treatment of chronic inflammatory conditions Inactive 18-Oct-2016
EP-3528809-A4 Mast cell stabilizers for treatment of chronic inflammatory conditions Inactive 18-Oct-2016
US-11478463-B2 Mast cell stabilizers for treatment of chronic inflammatory conditions Active 18-Oct-2016
US-20200215049-A1 Mast cell stabilizers for treatment of chronic inflammatory conditions Active 18-Oct-2016 A61K31/4535
To view Emergo Therapeutics’s complete patent history, request access »

Emergo Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Emergo Therapeutics FAQs

  • When was Emergo Therapeutics founded?

    Emergo Therapeutics was founded in 2016.

  • Where is Emergo Therapeutics headquartered?

    Emergo Therapeutics is headquartered in Durham, NC.

  • What is the size of Emergo Therapeutics?

    Emergo Therapeutics has 8 total employees.

  • What industry is Emergo Therapeutics in?

    Emergo Therapeutics’s primary industry is Drug Discovery.

  • Is Emergo Therapeutics a private or public company?

    Emergo Therapeutics is a Private company.

  • What is Emergo Therapeutics’s current revenue?

    The current revenue for Emergo Therapeutics is .

  • How much funding has Emergo Therapeutics raised over time?

    Emergo Therapeutics has raised $16.6M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process